Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, Beck J, Bornemann-Kolatzki K, Schütz E, Bachmann F, Halleck F, von Hoerschelmann E, Koch N, Schrezenmeier E, Seelow E, Waiser J, Zukunft B, Eckardt KU, Halbritter J, Kettritz R, Del Moral CL, Lachmann N, Stauch D, Niemann M, Schmidt D, Halloran PF, Osmanodja B. Akifova A, et al. Among authors: schrezenmeier e. Nephrol Dial Transplant. 2024 Nov 29:gfae282. doi: 10.1093/ndt/gfae282. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39673311
Continuous Glucose Monitoring for the Diagnosis of Post-Transplantation Diabetes Mellitus and Impaired Glucose Tolerance From Years One to Five After Kidney Transplantation-A Prospective Pilot Study.
Eleftheriadis G, Naik MG, Osmanodja B, Liefeldt L, Halleck F, Choi M, Schrezenmeier E, Zukunft B, Tura A, Budde K. Eleftheriadis G, et al. Among authors: schrezenmeier e. Transpl Int. 2024 Nov 15;37:13724. doi: 10.3389/ti.2024.13724. eCollection 2024. Transpl Int. 2024. PMID: 39620148 Free PMC article.
Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation-A prospective proof-of-concept study.
Eleftheriadis G, Naik MG, Osmanodja B, Liefeldt L, Choi M, Halleck F, Schrezenmeier E, Eckardt KU, Pigorsch M, Tura A, Kurnikowski A, Hecking M, Budde K. Eleftheriadis G, et al. Among authors: schrezenmeier e. Am J Transplant. 2024 Dec;24(12):2225-2234. doi: 10.1016/j.ajt.2024.07.016. Epub 2024 Jul 22. Am J Transplant. 2024. PMID: 39047976 Free article.
Dysregulation of immune checkpoint molecules as a characteristic of autoimmune congenital heart block.
Stefanski AL, Rincon-Arevalo H, Dressler-Steinbach I, Nomovi N, Mackert A, Aue A, Ritter J, Wiedemann A, Szelinski F, Schrezenmeier E, Kühl AA, Lino AC, Henrich W, Dörner T. Stefanski AL, et al. Among authors: schrezenmeier e. Ann Rheum Dis. 2024 Oct 21;83(11):1598-1600. doi: 10.1136/ard-2024-226176. Ann Rheum Dis. 2024. PMID: 38997131 No abstract available.
Successful Desensitization with Imlifidase and Daratumumab in a Highly Immunized, Crossmatch Positive, Blood Group-Incompatible Living-Donor Re-Transplant Recipient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Schrezenmeier E, Choi M, Globke B, Dörner T, Leimbach A, Osmanodja B, Schramm A, Amann K, Eckardt KU, Budde K, Öllinger R, Lachmann N, Halleck F. Schrezenmeier E, et al. Transfus Med Hemother. 2024 Apr 22;51(3):158-163. doi: 10.1159/000538513. eCollection 2024 Jun. Transfus Med Hemother. 2024. PMID: 38867806 Free PMC article.
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: schrezenmeier e. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets.
Ritter J, Szelinski F, Aue A, Stefanski AL, Rincon-Arevalo H, Chen Y, Nitschke E, Dang VD, Wiedemann A, Schrezenmeier E, Lino AC, Dörner T. Ritter J, et al. Among authors: schrezenmeier e. J Autoimmun. 2024 Jul;147:103243. doi: 10.1016/j.jaut.2024.103243. Epub 2024 May 24. J Autoimmun. 2024. PMID: 38788537 Free article.
Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow.
Ferreira-Gomes M, Chen Y, Durek P, Rincon-Arevalo H, Heinrich F, Bauer L, Szelinski F, Guerra GM, Stefanski AL, Niedobitek A, Wiedemann A, Bondareva M, Ritter J, Lehmann K, Hardt S, Hipfl C, Hein S, Hildt E, Matz M, Mei HE, Cheng Q, Dang VD, Witkowski M, Lino AC, Kruglov A, Melchers F, Perka C, Schrezenmeier EV, Hutloff A, Radbruch A, Dörner T, Mashreghi MF. Ferreira-Gomes M, et al. Among authors: schrezenmeier ev. Nat Commun. 2024 May 17;15(1):4182. doi: 10.1038/s41467-024-48570-0. Nat Commun. 2024. PMID: 38755157 Free PMC article.
89 results